Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Progressive MS”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Large-scale testing (Phase 3)Study completedNCT00087529
What this trial is testing

Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 439
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Testing effectiveness (Phase 2)UnknownNCT02273635
What this trial is testing

Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS

Who this might be right for
Primary Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive
Innobioscience SpA 68
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Post-approval studies (Phase 4)Study completedNCT02208050
What this trial is testing

The Effectiveness of Fampridine in Improving Upper Limb Function in MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
University College Dublin 64
Not applicableLooking for participantsNCT07222618
What this trial is testing

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+3 more
University of California, San Francisco 300
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Not applicableStudy completedNCT04550650
What this trial is testing

Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients

Who this might be right for
Multiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Primary Progressive
Somogy Megyei Kaposi Mór Teaching Hospital 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06384976
What this trial is testing

KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis+1 more
Kyverna Therapeutics 120
Not applicableStudy completedNCT07264725
What this trial is testing

Libyan Multiple Sclerosis Registry Study

Who this might be right for
Multiple Sclerosis
University of Zintan 369
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Early research (Phase 1)UnknownNCT00220493
What this trial is testing

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisMultiple Sclerosis, Chronic Progressive
Sheba Medical Center 80
Not applicableStudy completedNCT04705610
What this trial is testing

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis (MS) Relapsing RemittingMultiple Sclerosis (MS) Primary Progressive+4 more
Association de Recherche Bibliographique pour les Neurosciences 76
Early research (Phase 1)Temporarily pausedNCT06677710
What this trial is testing

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple Sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)+8 more
Indapta Therapeutics, INC. 34
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Not applicableActive Not RecruitingNCT03983681
What this trial is testing

Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

Who this might be right for
Multiple Sclerosis
Kessler Foundation 120
Post-approval studies (Phase 4)Study completedNCT01970410
What this trial is testing

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

Who this might be right for
Multiple Sclerosis
Providence Health & Services 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Load More Results